StreetInsider.com News Articles

Form 8-K Spectral AI, Inc. For: Jul 07

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747478.html

Form 8-K Spectral AI, Inc. For: Jul 07

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747478.html

Spectral AI names Darcy Bajko as chief commercial officer

Wed, 08 Jul 2026 08:30:09 -0400

Spectral AI, Inc. (Nasdaq: MDAI) announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Bajko will oversee commercial operations for the global launch of the company's DeepView System for burn indication, which received De Novo Classification from the U.S. Food and Drug Administration in May 2026.

Bajko joins Spectral AI from MediView XR, where she spent five years in commercial leadership roles, most recently as Vice President of Commercialization and Customer Success. At MediView XR, she was involved in launching three FDA-cleared augmented reality imaging platforms. Before that, she held commercial roles at Smith+Nephew, Integra LifeSciences,

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Wed, 08 Jul 2026 08:30:00 -0400

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView^® System for burn indication, which was granted De Novo Classification by the U.S. Food

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Wed, 08 Jul 2026 08:30:00 -0400

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

Form 4 Spectral AI, Inc. For: Jun 24 Filed by: DiMaio John Michael

Mon, 29 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260629/26706293.html

Form 4 Spectral AI, Inc. For: Jun 24 Filed by: DiMaio John Michael

Mon, 29 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260629/26706293.html

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

Thu, 25 Jun 2026 08:30:00 -0400

Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds

DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17^th – 19^th at the Nottingham Trent University, Nottingham, England.

The Company’s DeepView^® System was on display and

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

Thu, 25 Jun 2026 08:30:00 -0400

Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds

The Company’s DeepView^® System was on display and

Spectral AI joins wound healing awareness initiative

Fri, 12 Jun 2026 08:30:10 -0400

Spectral AI Inc. (NASDAQ: MDAI) announced its participation in the American Board of Wound Management Foundation's 10th Annual Wound Healing Awareness Month during June.

The Dallas-based artificial intelligence company develops medical diagnostic tools for wound care treatment decisions. Its DeepView System received FDA De Novo Classification in May 2026 for burn wound assessment.

"Wound Healing Awareness Month is an important reminder that patients living with painful, sometimes complex burn wounds require a timely, accurate diagnosis and a tailored treatment pathway," said Vincent Capone, Chief Executive Officer of Spectral AI.

The DeepView System uses multispectral imaging combined with artificial intelligence algorithms to evaluate healing

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Fri, 12 Jun 2026 08:30:00 -0400

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10^th Annual Wound Healing Awareness Month.

In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives.

“Wound Healing Awareness Month is an important reminder that patients living

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Fri, 12 Jun 2026 08:30:00 -0400

In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives.

“Wound Healing Awareness Month is an important reminder that patients living

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Thu, 11 Jun 2026 08:30:00 -0400

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its participation in the upcoming British Burn Association (“BBA”) Annual Meeting, being held June 17-19, 2026 at the Nottingham Trent University, Nottingham, England.

The Company’s DeepView^® System will be on display at Stand #22 and will be the subject of multiple podium and poster presentations during the conference.

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Thu, 11 Jun 2026 08:30:00 -0400

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

The Company’s DeepView^® System will be on display at Stand #22 and will be the subject of multiple podium and poster presentations during the conference.

Form 8-K Spectral AI, Inc. For: May 29

Mon, 01 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26583342.html

Form 8-K Spectral AI, Inc. For: May 29

Mon, 01 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26583342.html

Form 4 Spectral AI, Inc. For: May 28 Filed by: DiMaio John Michael

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583291.html

Form 4 Spectral AI, Inc. For: May 28 Filed by: DiMaio John Michael

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583291.html

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Mon, 01 Jun 2026 08:00:00 -0400

Provides Update and Outlook Following Receipt of FDA De Novo Clearance for DeepView® System for Burn Indication

DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026.

The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Mon, 01 Jun 2026 08:00:00 -0400

Provides Update and Outlook Following Receipt of FDA De Novo Clearance for DeepView® System for Burn Indication

The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from

Form 4 Spectral AI, Inc. For: May 26 Filed by: DiMaio John Michael

Wed, 27 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26559133.html

Form 4 Spectral AI, Inc. For: May 26 Filed by: DiMaio John Michael

Wed, 27 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26559133.html

Form 8-K Spectral AI, Inc. For: May 26

Tue, 26 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260526/26549678.html

Form 8-K Spectral AI, Inc. For: May 26

Tue, 26 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260526/26549678.html

Spectral AI (MDAI) PT Raised to $4 at BTIG

Tue, 26 May 2026 08:08:05 -0400

(Updated - May 26, 2026 8:08 AM EDT)

BTIG analyst Ryan Zimmerman raised the price target on Spectral AI (NASDAQ: MDAI) to $4.00 (from $3.00) while maintaining a Buy rating.

The analyst commented: "This morning, MDAI announced it received FDA clearance for the DeepView System for Burn Centers, Trauma Centers, and Emergency Departments. FDA clearance is a significant milestone for MDAI as the DeepView System has been in development and clinical investigation for numerous years. With clearance now secured, MDAI expects to begin its commercial launch in 2H26 and has previously noted that BARDA will support the distribution of ~30 systems into